These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 17998837)
1. The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study. Lata J; Novotný I; Príbramská V; Juránková J; Fric P; Kroupa R; Stibůrek O Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1111-3. PubMed ID: 17998837 [TBL] [Abstract][Full Text] [Related]
2. [Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis]. Lata J; Juránková J; Príbramská V; Fric P; Senkyrík M; Díte P; Kroupa R Vnitr Lek; 2006 Mar; 52(3):215-9. PubMed ID: 16722152 [TBL] [Abstract][Full Text] [Related]
3. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Liu Q; Duan ZP; Ha DK; Bengmark S; Kurtovic J; Riordan SM Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774 [TBL] [Abstract][Full Text] [Related]
4. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial. Bode C; Schäfer C; Fukui H; Bode JC Alcohol Clin Exp Res; 1997 Nov; 21(8):1367-73. PubMed ID: 9394106 [TBL] [Abstract][Full Text] [Related]
5. Changes of plasma D(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis. Ruan P; Gong ZJ; Zhang QR Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):58-61. PubMed ID: 14969839 [TBL] [Abstract][Full Text] [Related]
6. Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study. Pereg D; Kotliroff A; Gadoth N; Hadary R; Lishner M; Kitay-Cohen Y Nutrition; 2011 Feb; 27(2):177-81. PubMed ID: 20452184 [TBL] [Abstract][Full Text] [Related]
7. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial. Lee SJ; Bose S; Seo JG; Chung WS; Lim CY; Kim H Clin Nutr; 2014 Dec; 33(6):973-81. PubMed ID: 24411490 [TBL] [Abstract][Full Text] [Related]
8. Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: a double-blind randomized controlled trial. Sharma B; Srivastava S; Singh N; Sachdev V; Kapur S; Saraya A J Clin Gastroenterol; 2011; 45(5):442-8. PubMed ID: 21135704 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of plasma endotoxin levels in patients with cirrhosis. Chan CC; Hwang SJ; Lee FY; Wang SS; Chang FY; Li CP; Chu CJ; Lu RH; Lee SD Scand J Gastroenterol; 1997 Sep; 32(9):942-6. PubMed ID: 9299675 [TBL] [Abstract][Full Text] [Related]
10. Plasma prekallikrein and endotoxemia in liver cirrhosis. van Vliet AC; van Vliet HH; Dzoljić-Danilović G; Wilson JH Thromb Haemost; 1981 Feb; 45(1):65-7. PubMed ID: 7018004 [TBL] [Abstract][Full Text] [Related]
11. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Madrid AM; Hurtado C; Venegas M; Cumsille F; Defilippi C Am J Gastroenterol; 2001 Apr; 96(4):1251-5. PubMed ID: 11316178 [TBL] [Abstract][Full Text] [Related]
13. The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Fric P; Zavoral M Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):313-5. PubMed ID: 12610327 [TBL] [Abstract][Full Text] [Related]
14. The role of the gut barrier function in the pathophysiology of viral liver cirrhosis. Choi Y; Jeon WK; Hwang SJ; Kim BI; Sohn CI; Park DI; Cho YK; Kim HJ; Park JH Hepatogastroenterology; 2011; 58(109):1244-7. PubMed ID: 21937387 [TBL] [Abstract][Full Text] [Related]
15. Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers. Henker J; Laass MW; Blokhin BM; Maydannik VG; Bolbot YK; Elze M; Wolff C; Schreiner A; Schulze J Pediatr Infect Dis J; 2008 Jun; 27(6):494-9. PubMed ID: 18469732 [TBL] [Abstract][Full Text] [Related]
16. Intestinal microflora in patients with liver cirrhosis. Zhao HY; Wang HJ; Lu Z; Xu SZ Chin J Dig Dis; 2004; 5(2):64-7. PubMed ID: 15612659 [TBL] [Abstract][Full Text] [Related]
17. Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study. Vleggaar FP; Monkelbaan JF; van Erpecum KJ Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):688-92. PubMed ID: 18679073 [TBL] [Abstract][Full Text] [Related]
18. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo. Enck P; Zimmermann K; Menke G; Klosterhalfen S Z Gastroenterol; 2009 Feb; 47(2):209-14. PubMed ID: 19197823 [TBL] [Abstract][Full Text] [Related]
19. Are total prostate-specific antigen serum levels in cirrhotic men different from those in normal men? Vicentini FC; Botelho LA; Hisano M; Ebaid GX; Lucon M; Lucon AM; Srougi M Urology; 2009 May; 73(5):1032-5. PubMed ID: 19286245 [TBL] [Abstract][Full Text] [Related]
20. The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial. Tromm A; Niewerth U; Khoury M; Baestlein E; Wilhelms G; Schulze J; Stolte M Z Gastroenterol; 2004 May; 42(5):365-9. PubMed ID: 15136935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]